Medically reviewed by Dr. Don Zone, MD, FACC, FAARM, Board-Certified Cardiologist · Last updated: October 2026

Disclosure: Dr. Zone formulated Longevion, an NMN supplement sold by Anti-Aging Today, and has a financial interest in its sale. This guide is based on published human trials, which are listed at the end.

The Short Answer

There’s no official daily dose for NAD+ itself, because you don’t really take NAD+. You take a precursor that your cells turn into NAD+, and the dose that matters is the precursor dose.

Based on human trials:

  • NMN (nicotinamide mononucleotide): 250–600 mg per day. In the largest dose-response trial in healthy middle-aged adults, benefits rose from 300 to 600 mg and leveled off at 900 mg.
  • NR (nicotinamide riboside): 250–1,000 mg per day. Higher doses raise blood NAD+ further but haven’t shown extra benefit in healthy adults.

For most healthy adults over 40, I suggest starting at the lower end of either range and staying there unless your doctor has a reason to go higher. More isn’t automatically better.

NAD+ vs. Precursor Dosing: Why You Dose the Precursor

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell uses to turn food into energy and to run repair processes. Levels fall with age, which is why it has become a focus of longevity research.

The problem is that NAD+ is a large, fragile molecule. Swallowed as a capsule, most of it is broken down in the gut before it reaches your cells, and we found no peer-reviewed human trial showing that oral NAD+ raises blood NAD+. Smaller precursor molecules, mainly NMN and NR, are absorbed and converted into NAD+ inside your cells. That’s why nearly every serious NAD+ supplement uses a precursor, and why every dose in this guide refers to the precursor. (For a deeper comparison, see NMN vs. NAD+ and NMN vs. NR.)

NMN Dosage: What the Trials Used

TrialDaily doseWho and how longWhat happened
Igarashi et al., 2022250 mgMen 65+, 12 weeksBlood NAD+ rose; small, nominally significant gains in gait speed and grip strength
Kim et al., 2022250 mg (morning vs. evening)108 adults 65+, 12 weeksEvening dosing showed the largest effect on a sit-to-stand test and daytime drowsiness
Yi et al., 2023300, 600 or 900 mg80 adults aged 40–65, 60 daysBlood NAD+ and walking endurance improved at every dose; results peaked at 600 mg, with no further gain at 900 mg
Liao et al., 2021300, 600 or 1,200 mg48 recreational runners, 6 weeksAerobic capacity measures improved at the higher doses
Fukamizu et al., 20221,250 mg31 healthy adults, 4 weeksSafety study: no serious adverse events

Bottom line for NMN: 250–600 mg per day is the best-supported range. Doses above 600 mg haven’t shown extra benefit in healthy middle-aged adults and cost more. For a full breakdown, read my NMN dosage guide.

NR Dosage: What the Trials Used

TrialDaily doseWho and how longWhat happened
Conze et al., 2019100, 300 or 1,000 mg140 overweight adults aged 40–60, 8 weeksBlood NAD+ rose with dose: about 22%, 51% and 142% within two weeks, and stayed up; no safety signals versus placebo
Dellinger et al., 2017250 mg NR + 50 mg pterostilbene (or double)120 adults aged 60–80, 8 weeksBlood NAD+ rose about 40% at the standard dose
Martens et al., 20181,000 mg (500 mg twice daily)Healthy adults 55–79, 6-week crossoverCellular NAD+ about 60% higher than placebo; well tolerated
Dollerup et al., 20182,000 mg40 men with obesity, 12 weeksSafe, but no improvement in insulin sensitivity or body composition
Berven et al., 20233,000 mg20 adults with Parkinson’s disease, 4 weeksWell tolerated in this short safety study; blood NAD+ rose substantially

Bottom line for NR: 250–1,000 mg per day covers the doses with the most human data. Blood NAD+ keeps climbing at 2,000–3,000 mg, but trials at those doses haven’t shown added benefit for healthy people, and they’re short. Unless you’re in a supervised study, there’s little reason to go above 1,000 mg.

When More Isn’t Better

It’s tempting to assume that if 300 mg is good, 1,000 mg must be better. The evidence doesn’t support that. In the NMN dose-response trial, blood NAD+ and walking endurance were no better at 900 mg than at 600 mg. For NR, higher doses raised blood NAD+ further, but the outcomes people care about, like insulin sensitivity or body composition, didn’t improve at 2,000 mg.

There’s also a practical reason to stay moderate. When your body breaks down NMN and NR, part of it becomes nicotinamide, and clearing extra nicotinamide uses methyl groups. Researchers have raised a theoretical concern that very high doses over long periods could strain methylation. The human evidence for harm is weak, but it’s one more reason not to megadose. Whether adding folate or B12 offsets this hasn’t been tested in humans.

Morning or Night? What the Timing Evidence Shows

Timing research is thin. For NMN, one 12-week trial in 108 adults aged 65 and older compared 250 mg taken in the morning with 250 mg taken in the evening (6 p.m. to bedtime). The evening group showed the largest improvements in a sit-to-stand test and in daytime drowsiness, although the trial wasn’t designed to prove one time was better.

For NR, I’m not aware of any trial that compared timing or taking it with versus without food. Most higher-dose NR studies split the dose into morning and evening servings.

My practical advice: take your precursor at the same time every day, since consistency matters more than the clock. Morning dosing is a sensible default and easy to remember with breakfast. If you’re 65 or older and want to follow the one trial we have, taking it in the evening is a reasonable choice.

Is It Safe? Side Effects and Upper Limits

In human trials lasting from a few weeks to a few months, NMN up to 1,250 mg/day and NR up to 2,000–3,000 mg/day were well tolerated, with side effects similar to placebo. Mild digestive upset and headache are the complaints people mention most. Unlike niacin (nicotinic acid), NR and NMN are not associated with the hot, itchy skin flushing that niacin causes.

A few reference points:

  • European regulators (EFSA) assessed NR chloride as safe at up to 300 mg/day for healthy adults in supplements. That’s a conservative, precautionary figure, not a ceiling where harm begins.
  • In September 2025, the FDA confirmed that NMN is not excluded from the definition of a dietary supplement, so it can be marketed as one in the U.S., subject to the same rules as other supplement ingredients.
  • Long-term data is limited. No trial has followed people taking NMN or NR for years.

Talk to your doctor before taking an NAD+ precursor if you:

  • Are pregnant or breastfeeding
  • Have active cancer or a recent cancer history
  • Take prescription medications, especially blood thinners, or have liver or kidney disease

What About IV, Sublingual or Nasal NAD+?

NAD+ IV drips are popular at wellness clinics, but they’re expensive and the evidence is thin. In a small pharmacokinetic study, a 750 mg infusion given slowly over six hours was cleared from the blood quickly at first, with plasma NAD+ rising only near the end. Infusions given faster commonly cause nausea, cramping, chest tightness and a racing heart. I’m not aware of a randomized trial showing that IV NAD+ improves health outcomes in healthy adults. Sublingual and nasal NAD+ products have no published human absorption trials at all.

For most people, an oral precursor at a studied dose is the better-evidenced, lower-cost option.

How Longevion Fits

Longevion provides 300 mg of NMN per two-capsule serving, inside the 250–600 mg range with the strongest human evidence. Rather than chasing a bigger number, I paired it with CoQ10, magnesium malate, methylated B vitamins and vitamin D3/K2 to support normal cellular energy production. If you’re comparing options, our NAD+ & NMN supplements page lists what we carry. Longevion contains vitamin K2, so if you take warfarin, check with your cardiologist first.

Frequently Asked Questions

How much NAD+ should I take per day?

You don’t take NAD+ directly; you take a precursor. Human trials support about 250–600 mg per day of NMN or 250–1,000 mg per day of NR. Most healthy adults over 40 can start at the lower end of either range.

Is 1,000 mg of NMN too much?

A 1,250 mg daily dose was well tolerated in a four-week safety study, so 1,000 mg isn’t known to be dangerous in the short term. But in a dose-response trial, benefits leveled off around 600 mg, so 1,000 mg likely adds cost without clear benefit.

Can you take too much NAD+ precursor?

Trials of NR at 2,000–3,000 mg per day reported no serious side effects over weeks to months, but long-term safety at high doses isn’t known. Very high doses also produce more nicotinamide for your body to clear. Staying within studied ranges is the safest approach.

Should I take NAD+ supplements in the morning or at night?

Consistency matters more than timing. Morning is a sensible default. One small trial in adults 65 and older found slightly better results when NMN was taken in the evening, so evening dosing is also reasonable.

Does NAD+ dosage change with age?

No trial has validated age-based dosing. Most studies enrolled adults over 40, and NAD+ levels decline with age, so older adults are the group most studied. The 250–600 mg NMN range applied across the ages tested.

Is IV NAD+ better than oral supplements?

There’s no good evidence that it is. IV NAD+ is costly, often causes side effects when infused quickly, and hasn’t been shown in randomized trials to improve health outcomes in healthy adults. Oral NMN or NR at studied doses reliably raises blood NAD+.

How long does it take for NAD+ supplements to work?

Blood NAD+ levels rose within two to eight weeks in most trials. Changes in how people felt or performed, when they occurred, were usually measured after 8–12 weeks of daily use.

Key Takeaways

  • You dose the precursor, not NAD+ itself, because oral NAD+ is poorly absorbed.
  • NMN: 250–600 mg per day is the best-supported range; benefits leveled off around 600 mg.
  • NR: 250–1,000 mg per day covers most human data; higher doses haven’t shown extra benefit in healthy adults.
  • Take it at the same time daily; morning is a sensible default, and evening dosing is reasonable for adults 65+.
  • IV, sublingual and nasal NAD+ lack good human evidence.
  • Check with your doctor if you’re pregnant, have a cancer history or take prescription medications.

Want help choosing a product? See how eight popular options compare in Best NAD+ Supplements of 2026, Ranked by a Cardiologist, or browse our NAD+ & NMN supplements.

References

  1. Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. 2022;8:5. doi:10.1038/s41514-022-00084-z
  2. Kim M, et al. Effect of 12-week intake of nicotinamide mononucleotide on sleep quality, fatigue, and physical performance in older Japanese adults: a randomized, double-blind placebo-controlled study. Nutrients. 2022;14(4):755. doi:10.3390/nu14040755
  3. Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29–43. doi:10.1007/s11357-022-00705-1
  4. Liao B, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18:54. doi:10.1186/s12970-021-00442-4
  5. Fukamizu Y, et al. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep. 2022;12:14442. doi:10.1038/s41598-022-18272-y
  6. Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Sci Rep. 2019;9:9772. doi:10.1038/s41598-019-46120-z
  7. Dellinger RW, et al. Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably. npj Aging Mech Dis. 2017;3:17. doi:10.1038/s41514-017-0016-9
  8. Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286. doi:10.1038/s41467-018-03421-7
  9. Dollerup OL, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108(2):343–353. doi:10.1093/ajcn/nqy132
  10. Berven H, et al. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease. Nat Commun. 2023;14. doi:10.1038/s41467-023-43514-6
  11. Grant R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019;11:257. doi:10.3389/fnagi.2019.00257
  12. EFSA Panel on Nutrition, Novel Foods and Food Allergens. Safety of nicotinamide riboside chloride as a novel food. EFSA J. 2019;17(8):5775. doi:10.2903/j.efsa.2019.5775
  13. Hwang ES, Song SB. Possible adverse effects of high-dose nicotinamide: mechanisms and safety assessment. Biomolecules. 2020;10(5):687. doi:10.3390/biom10050687
  14. U.S. Food and Drug Administration. Response to citizen petition FDA-2023-P-0872 regarding NMN, September 29, 2025. regulations.gov

About the author: Dr. Don Zone, MD, FACC, FAARM, is a board-certified cardiologist and Fellow of the American Academy of Anti-Aging Medicine. He formulated Longevion and has a financial interest in its sale.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes and is not a substitute for advice from your physician.